M. Nieves Calvo-Vidal

Five-year follow-up of lenalidomide plus rituximab as initial treatment of mantle cell lymphoma

Jia Ruan, Peter Martin, Paul J. Christos et al. · Blood · 2018 · 123 citations · Full text

Medicine, Hematology, Oncology +12

THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors

Florencia Cayrol, Pannee Praditsuktavorn, Tharu M. Fernando et al. · Nature Communications · 2017 · 111 citations · Full text

Medicine, Cancer Biology, Oncology +13

Functional screen of MSI2 interactors identifies an essential role for SYNCRIP in myeloid leukemia stem cells

Ly Vu, Camila Prieto, Elianna Amin et al. · Nature Genetics · 2017 · 106 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +11

Germline Lysine-Specific Demethylase 1 ( <i>LSD1/KDM1A</i> ) Mutations Confer Susceptibility to Multiple Myeloma

Xiaomu Wei, M. Nieves Calvo-Vidal, Siwei Chen et al. · Cancer Research · 2018 · 82 citations · Full text

Medicine, Genetics, Molecular Genetics +17

TP53 induced glycolysis and apoptosis regulator (TIGAR) knockdown results in radiosensitization of glioma cells

M. A. Peña-Rico, M. Nieves Calvo-Vidal, Ruth Villalonga-Planells et al. · Radiotherapy and Oncology · 2011 · 78 citations · Full text

Medicine, Cancer Biology, Oncology +14